SCHEMBL26340952

SCHEMBL26340952

c1ccc(-c2ccccc2N(c2ccccc2)c2ccc(-c3ccc4c(-c5ccccc5)c(-c5ccccc5)c5ccccc5c4c3)cc2)cc1

nearest known ligand 0.32

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 1/20 0.32
▸ ESR2 Q92731 1/20 0.32
▸ PIK3CA P42336 1/20 0.31
▸ MEN1 O00255 2/20 0.31
▸ MAPT P10636 2/20 0.31
▸ KMT2A Q03164 2/20 0.31
▸ ATM Q13315 2/20 0.31
▸ L3MBTL1 Q9Y468 2/20 0.31
▸ APAF1 O14727 1/20 0.31
▸ NPC1 O15118 1/20 0.31
▸ LMNA P02545 1/20 0.31
▸ THRB P10828 1/20 0.31
▸ XBP1 P17861 1/20 0.31
▸ PTBP1 P26599 1/20 0.31
▸ HTT P42858 1/20 0.31
▸ RAB9A P51151 1/20 0.31
▸ GALK1 P51570 1/20 0.31
▸ BLM P54132 1/20 0.31
▸ SMAD3 P84022 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22670398 0.99 ESR1 (0.33) ESR1ESR2PIK3CAMEN1MAPT
SCHEMBL26340761 0.97 ESR1 (0.32) ESR1ESR2PIK3CAMEN1MAPT
SCHEMBL26340989 0.96 ESR1 (0.33) ESR1ESR2PIK3CAMEN1MAPT
SCHEMBL26340712 0.96 ESR1 (0.33) ESR1ESR2PIK3CAMEN1MAPT
SCHEMBL26340743 0.96 ESR1 (0.33) ESR1ESR2PIK3CAMEN1MAPT
SCHEMBL26340993 0.95 ENPP1 (0.32) ESR1ESR2PIK3CAMEN1MAPT
SCHEMBL24029533 0.94 MAPT (0.34) ESR1PIK3CAMEN1MAPTKMT2A
SCHEMBL26340674 0.93 IMPDH2 (0.32) ESR1ESR2IMPDH2ENPP1CRHR1
SCHEMBL26338279 0.93 IMPDH2 (0.32) ESR1ESR2IMPDH2ENPP1CRHR1
SCHEMBL26340980 0.93 IMPDH2 (0.32) ESR1ESR2IMPDH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230301176-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENTS, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-09-21 — — US disclosed
US-20230301176-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENTS, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-09-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230301176-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENTS, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE LEF1, ELAVL1, PIEZO1 ESR1 74/4885ESR2 419/4885PIK3CA 4384/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback